Back to top

GILD Maintains Rating by RBC Capital -- Price Target Raised to $123

GILD Maintains Rating by RBC Capital -- Price Target Raised to $123

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)